Olpadronate prevents the bone loss induced by cyclosporine in the rat

Calcified Tissue International

Volumn 70, Issue 1, 2002, Pages 48-53

  Zeni, Susana N ^a   Di Gregorio, S ^a   Gomez, A C ^a   Somoza, J ^a   Mautalen, C ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

BMD; Cyclosporine; Deoxypyridino line; Olpadronate; Rats

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; BISPHOSPHONIC ACID DERIVATIVE; CYCLOSPORIN; DEOXYPYRIDINOLINE; IMMUNOSUPPRESSIVE AGENT; OLPADRONIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; CYCLOSPORIN A;

ANIMAL; ARTICLE; BLOOD; BONE; BONE DENSITY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; RADIODENSITOMETRY; RADIOGRAPHY; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; URINE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG EFFICACY; FEMUR; IMMUNOSUPPRESSIVE TREATMENT; LUMBAR SPINE; NONHUMAN; OSTEOPENIA; PRIORITY JOURNAL; TIBIA; TRABECULAR BONE;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; AMINO ACIDS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CYCLOSPORINE; DENSITOMETRY, X-RAY; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 0036363803     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-1085-z     Document Type: Article

References (23)

1. Epstein S (1996) Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:1-7
2. Katz IA, Epstein S (1992) Posttransplantation bone disease. J Bone Miner Res 7:123-126
3. Kawana K, Takahashi M, Kushida K, Hoshino H, Sakata S, Inoue T (1996) The effect of cyclosporin A administration on bone metabolism in the rat evaluated by biochemical markers. J Endocrinol Invest 19:499-504
4. Stein B, Takizawa M, Katz I, Joffe I, Berlin J, Fallon M, Epstein S (1991) Salmon calcitonin prevents cyclosporin A-induced high turnover bone loss. Endocrinology 129:92-98
5. Orcel P, Bielakoff J, Modrowski D, Miravet L, de Vernejoul MC, (1989) Cyclosporin A induced in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res 3:387-391
6. Sass D, Bowman A, Yuan Z, Ma Y, Jee WSS, Epstein S (1997) Alendronate prevents cyclosporin A-induced osteopenia in the rat. Bone 21:65-70
7. Fleisch H (1995) Bisphosphonates in bone disease, 2nd ed. The Parthenon Publishing Group Inc, NY
8. Zeni S, Gomez-Acotto C, Mautalen C (1997) Olpadronate prevents thyroxine-induced osteopenia in OVX rats. Bone 21:329-333
9. Zeni S, Gomez-Acotto C, Di Gregorio S, Mautalen C (2000) Differences in bone turnover and skeletal response to thyroid hormone treatment between estrogen-depleted and repleted rats. Calcif Tissue Int 67:173-177
10. Robins S, Woitge H, Hesley R, Ju J, Seyedin S, Seibel M (1994) Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643-1649
11. Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang XG, Ke HZ, Jee W, Epstein S (1994) Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo. J Bone Miner Res 9:59-67
12. Katz IA, Jee WS, Joffe I, Stein B, Takizawa M, Jacobs T, Setterberg R, Lin B, Tang L, Ke H, Zeng Q, Berlin J, Epstein S (1992) Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat. J Bone Miner Res 10:1191-1200
13. Epstein S, Schlosberg M, Fallen M, Thomas S, Movsowitz C, Ismail F (1990) 1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone loss. Calcif Tissue Int 47:152-157
14. Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallen MD, Thomas S (1989) The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179-2184
15. Epstein S, Takizawa M, Stein B, Katz I, Joffe I, Romero D, Liang X, Li M, Ke H, Jee WS, Jacobs T, Berlin J (1994) Effect of cyclosporin A on bone metabolism in experimental diabetes mellitus in the rat. J Bone Miner Res 4:557-566
16. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S (1988) Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinolgy 123:2571-2577
17. Bryer H, Isserow J, Armstrong E, Mann G, Rucinski B, Buchinsky F, Romero D, Epstein S (1995) Azathioprine alone is bone sparing and does not after cyclosporin A-induced osteopenia in the rat. J Bone Miner Res 10 (1):132-139
18. del Pozo E, Lippuner K, Ruch WS, Casez J, Payne T, MacKenzie A, Jaeger P (1995) Different effects of cyclosporin A on bone remodeling in young and adult rats. Bone 16:S271-S275
19. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S (1989) Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 4:393-398
20. Klein L, Lemel M, Wolfe M, Shaffer J (1994) Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat. Calcif Tissue Int 55:295-301
21. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725-1738
22. th ed. USA, Ac Press
23. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S (1990) The bisphosphonate 2-PEBP inhibits cyclosporin A-induced high-turnover osteopenia in the rat. J Lab Clin Med 115:62-68